BD (NYSE: BDX) announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue ...

A major American medical device manufacturer is investing $110 million to expand production in Nebraska as part of an effort ...

Xtandi, Astellas’ roughly $6 billion prostate cancer juggernaut by annual sales, is set to lose U.S. patent protection in ...

Becton, Dickinson and Co. will invest more than $110M to expand a Nebraska syringe facility, add 120 jobs and support ...

The move comes in response to increasing delivery demands for GLP-1s, plus broader conversations about pharmaceutical ...

Navigate Commercial Finance, the Birmingham-based SME finance broker, is pleased to announce the appointment of Cormac Parize ...

It might be time to circle back on Bo Bichette. This is what MLB.com wrote on Thursday night: ...

Foster & Partners jumps 10 places in BD's survey of the world's largest practices and sees turnover jump by 55% ...

Strokes are a medical emergency, yet imaging can capture only snapshots of how brain damage develops in the hours and days ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host its virtual 2026 Annual Meeting of Shareholders (the "Annual Meeting") on ...

BD (Becton, Dickinson and Company) has announced a $110m investment to expand its production of prefillable syringes in the ...

A former student said the teacher assaulted him after offering "BD Bucks," a fake currency the school used to reward good ...